Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135.
David P Sonne, Bianca Hemmingsen
https://pubmed.ncbi.nlm.nih.gov/28637892/Actively Recruiting
Led by University of Hawaii · Updated on 2026-07-02
50
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are evaluating the effects of daily consumption of fermented poi on the maternal microbiome and the risk of gestational diabetes during pregnancy. This pilot study involves fifty pregnant participants between approximately 12 and 24 weeks of gestation and aims to inform the feasibility and design of a larger culturally grounded dietary intervention for preventing gestational diabetes. The study focuses on assessing changes in the vaginal, oral, and rectal microbiome, diet quality, gestational diabetes diagnosis, and pregnancy outcomes compared with matched controls from an existing cohort. Eligible participants will undergo a brief dietary washout period avoiding poi and other fermented foods. Then, they will receive one pound of fermented poi daily for 28 consecutive days during the second trimester, combined with culturally tailored nutrition education delivered through secure text messaging. This single-group, non-randomized intervention is designed to monitor the effects of fermented poi consumption over one month. Participants will complete assessments at enrollment, baseline, mid-point, end of intervention, and long-term follow-up in the third trimester. Self-collected vaginal swabs and optional oral and rectal swabs will be used to analyze the maternal microbiome. Researchers will also collect anthropometric data, blood pressure, dietary intake through mobile food records, and questionnaires covering pregnancy characteristics and psychosocial factors. With participant consent, health care providers will share information on gestational diabetes diagnosis and labor and delivery outcomes. These results will be compared to matched controls with little or no poi consumption.
CONDITIONS
Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
M
Marie Kainoa Fialkowski Revilla
T
Tomomi Otaki
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Hawaii
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Daily Fermented Poi Consumption | Current-Care Recommendations |
|---|---|---|
| What it is | Participants consume one pound of fermented poi daily for 28 days as the investigational dietary intervention. | Pregnant individuals are advised to follow evidence-based dietary and lifestyle recommendations to help prevent or reduce the risk of gestational diabetes. |
| Role in study or care | Studied as an investigational probiotic dietary intervention for microbiome modulation and gestational diabetes risk. | Serves as the established approach for GDM prevention and care in general pregnancy populations. |
| Primary use or intent | Intended to modulate the maternal microbiome and reduce gestational diabetes risk by introducing regular probiotic-rich poi consumption. | Designed to help prevent or manage gestational diabetes through balanced nutrition and lifestyle modification during pregnancy. |
| How it is given or performed | Daily intake of one pound of fermented poi, provided to participants, for a 28-day period. Adherence is monitored through study activities and reporting. | Participants are advised to consume a balanced diet low in added sugars and refined grains, high in fiber-rich foods, with emphasis on regular meals and healthy physical activity as recommended by guidelines. |
| Evidence status | Currently being evaluated in an ongoing pilot trial; no published patient outcome data yet for fermented poi in GDM risk reduction. | Supported by current clinical guidelines and multiple studies showing that dietary and lifestyle modification can reduce gestational diabetes incidence in at-risk pregnant women. |
| Important limitations | Not yet established as effective for GDM risk reduction; effect on the maternal microbiome and clinical outcomes remains to be determined. Only pregnant people meeting the trial's specific geographic and program criteria can participate. | Diet and lifestyle modification require sustained motivation and support; effectiveness may be limited by individual adherence and access to resources. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants consume one pound of fermented poi daily for 28 days during the second trimester and receive nutrition education via text messages.
Assessments at enrollment, baseline, mid-point, end of intervention, and long-term follow-up
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Have more questions? Get in touch with our team for quick support
David P Sonne, Bianca Hemmingsen
https://pubmed.ncbi.nlm.nih.gov/28637892/Amy C Brown, Anne Shovic, Salam A Ibrahim...
https://pubmed.ncbi.nlm.nih.gov/15712767/Megan Y Kawamura, Marjorie K Mau, Reni Soon...
https://pubmed.ncbi.nlm.nih.gov/35261986/Ethan Slouha, Kaitlyn M Gates, Hanin Al-Geizi...
https://pubmed.ncbi.nlm.nih.gov/38435884/María José Calvo, Heliana Parra, Raquel Santeliz...
https://pubmed.ncbi.nlm.nih.gov/38812661/Chinyere L Ikoh Rph, Roland Tang Tinong
https://pubmed.ncbi.nlm.nih.gov/37664380/Ali Shahriari, Elham Karimi, Mohammadali Shahriari...
https://pubmed.ncbi.nlm.nih.gov/34328109/Diego Dos Santos Baião, Cyntia Silva de Freitas, Laidson Paes Gomes...
https://pubmed.ncbi.nlm.nih.gov/28930173/Caroline K Kramer, Sara Campbell, Ravi Retnakaran
https://pubmed.ncbi.nlm.nih.gov/30843102/Anna-Maaria Auvinen, Kaisu Luiro, Jari Jokelainen...
https://pubmed.ncbi.nlm.nih.gov/32725280/University of Hawaii
Lead Sponsor